title: Refractory pseudoseptic arthritis in Behçet's disease successfully treated with infliximab: a case report and literature review.
abstract: Arthritis associated with Behçet's disease is typically nonerosive and nondeforming, and most patients respond to colchicine treatment. However, destructive arthritis and refractory arthritis have also been reported on occasion. Elevated white blood cell counts may occur in synovial fluid in BD, but pseudoseptic arthritis is a very rare event in this disease. We report a patient with BD and rapidly progressive deforming pseudoseptic arthritis refractory to colchicine, corticosteroids, and methotrexate, who entered remission after infliximab treatment.
authors.affiliation: Department of Rheumatology, University Hospital Ramón y Cajal Ctra , Colmenar Viejo Km. 9,100, 28034 Madrid , Spain.
authors.forename: Walter Alberto
authors.initials: WA
authors.lastname: Sifuentes Giraldo
authors.forename: Carlos Antonio
authors.initials: CA
authors.lastname: Guillén Astete
authors.forename: Claudia
authors.initials: C
authors.lastname: Murillo Romero
authors.forename: Irene
authors.initials: I
authors.lastname: Amil Casas
authors.forename: Ana María
authors.initials: AM
authors.lastname: Rodríguez García
authors.forename: Francisco Javier
authors.initials: FJ
authors.lastname: Bachiller Corral
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000150:complications / Q000188:drug therapy*; D001528:Behcet Syndrome / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008297:Male; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab